Loading…

Autoimmunity and autoimmune co‐morbidities in psoriasis

Summary Psoriasis is characterized by widespread scaly erythematous plaques that cause significant physical and psychological burdens for the affected individuals. Accelerated inflammation driven by the tumour necrosis factor‐α/interleukin‐23/interleukin‐17 axis is now known to be the major mechanis...

Full description

Saved in:
Bibliographic Details
Published in:Immunology 2018-05, Vol.154 (1), p.21-27
Main Authors: Furue, Kazuhisa, Ito, Takamichi, Tsuji, Gaku, Kadono, Takafumi, Nakahara, Takeshi, Furue, Masutaka
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Psoriasis is characterized by widespread scaly erythematous plaques that cause significant physical and psychological burdens for the affected individuals. Accelerated inflammation driven by the tumour necrosis factor‐α/interleukin‐23/interleukin‐17 axis is now known to be the major mechanism in the development of psoriasis. In addition, psoriasis has an autoimmune nature that manifests as autoreactive T cells and is co‐morbid with other autoimmune diseases, such as autoimmune bullous diseases, vitiligo, alopecia and thyroiditis. In this article, we review the recent topics on autoimmunity and autoimmune co‐morbidities in psoriasis. Psoriasis is driven by the tumour necrosis factor‐α/interleukin‐23/interleukin‐17 axis. It has an autoimmune nature and is also co‐morbid with other autoimmune diseases such as autoimmune bullous diseases, vitiligo, alopecia and thyroiditis.
ISSN:0019-2805
1365-2567
DOI:10.1111/imm.12891